🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Endothelial Extracellular Vesicles as Biomarkers of Endothelial Activation in Adults With Newly Diagnosed Hypertension

Recruitingn/aAges 18 Years - anyAllJosip Juraj Strossmayer University of Osijek
NCT07728630 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Hypertension is associated with endothelial dysfunction, an early event in the development of cardiovascular disease. Endothelial extracellular vesicles (EEVs) have emerged as promising biomarkers of endothelial activation and vascular injury; however, their relationship with blood pressure and microvascular endothelial function in untreated hypertension remains insufficiently understood. This observational case-control study aims to compare circulating EEV concentrations between normotensive adults and adults with newly diagnosed, untreated primary hypertension. In addition, the study will investigate the associations between EEV levels, blood pressure, microvascular endothelial function assessed by laser Doppler flowmetry, and established circulating biomarkers of endothelial activation. The findings may improve understanding of the role of EEVs in early hypertension and support their

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older. * Ability and willingness to provide written informed consent. * Normotensive individuals or individuals with newly diagnosed, previously untreated primary hypertension, classified according to the European Society of Hypertension (ESH) guidelines. * Ability to comply with all study procedures. Exclusion Criteria: * Secondary hypertension. * Previous treatment with antihypertensive medication. * History of cardiovascular disease (except newly diagnosed primary hypertension in the hypertensive group). * Diabetes mellitus. * Chronic kidney disease. * Cerebrovascular disease. * Peripheral arterial disease. * Acute or chronic inflammatory or infectious disease. * Active malignancy. * Pregnancy or breastfeeding. * Current use of oral contraceptives, hormone replacement therapy, or medications known to affect endothelial function. * Inability or unwillingness to provide informed consent.
💊

What it tests

  • Not listed
📍

Where

1 site
Faculty of Medicine Osijek
Osijek, Croatia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy